Literature DB >> 12854626

Bacterial infections in patients requiring admission for an acute exacerbation of COPD; a 1-year prospective study.

Karin H Groenewegen1, Emiel F M Wouters.   

Abstract

STUDY
OBJECTIVE: To investigate the frequency of respiratory bacterial infections in hospitalized patients, admitted with an acute exacerbation of chronic obstructive pulmonary disease (COPD), to identify the responsible pathogens by sputum culture and to assess patient characteristics in relation to sputum culture results.
METHODS: We prospectively evaluated clinical data and sputum culture results of 171 patients, admitted to the pulmonology department of the University Hospital Maastricht with an acute exacerbation of COPD from 1st January 1999 until 31st December 1999.
RESULTS: Eighty-five patients (50%) had positive sputum cultures, indicating the presence of bacterial infection. Pathogens most frequently isolated were: Haemophilus influenzae (45%), Streptococcus pneumoniae (27%), and Pseudomonas aeruginosa (15%). Patients with more severely compromised lung function had a higher incidence of bacterial infections (P = 0.026). There were no significant differences in age, lung function parameters, blood gas results and length of hospital stay between patients with and without bacterial infection. There were no correlations between the type of bacteria isolated and clinical characteristics.
CONCLUSION: Incidence of bacterial infection during acute exacerbations of COPD is about 50%. Patients with and without bacterial infection are not different in clinical characteristics or in outcome parameters. Patients with lower FEV1 have a higher incidence of bacterial infections, but there is no difference in the type of bacterial infection. In the future, the pathogenic role of bacterial infection in exacerbations of COPD should be further investigated, especially the role of bacterial infection in relation to local and systemic inflammation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12854626     DOI: 10.1016/s0954-6111(03)00026-x

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  27 in total

1.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

2.  Prevention of lung injury by Muc1 mucin in a mouse model of repetitive Pseudomonas aeruginosa infection.

Authors:  Tsuyoshi Umehara; Kosuke Kato; Yong Sung Park; Erik P Lillehoj; Hideyuki Kawauchi; Kwang Chul Kim
Journal:  Inflamm Res       Date:  2012-05-29       Impact factor: 4.575

3.  Application of loop-mediated isothermal amplification (LAMP) assay for the rapid diagnosis of pathogenic bacteria in clinical sputum specimens of acute exacerbation of COPD (AECOPD).

Authors:  Wei Zhang; Chuanhui Chen; Jian Cui; Wei Bai; Jing Zhou
Journal:  Int J Clin Exp Med       Date:  2015-05-15

4.  A Comparison between Two Pathophysiologically Different yet Microbiologically Similar Lung Diseases: Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.

Authors:  Daniel E Fenker; Cameron T McDaniel; Warunya Panmanee; Ralph J Panos; Eric J Sorscher; Carleen Sabusap; John P Clancy; Daniel J Hassett
Journal:  Int J Respir Pulm Med       Date:  2018-11-29

5.  Systemic humoral immunity to non-typeable Haemophilus influenzae.

Authors:  P T King; J Ngui; D Gunawardena; P W Holmes; M W Farmer; S R Holdsworth
Journal:  Clin Exp Immunol       Date:  2008-09       Impact factor: 4.330

6.  Binding of complement regulators to invasive nontypeable Haemophilus influenzae isolates is not increased compared to nasopharyngeal isolates, but serum resistance is linked to disease severity.

Authors:  Teresia Hallström; Fredrik Resman; Mikael Ristovski; Kristian Riesbeck
Journal:  J Clin Microbiol       Date:  2010-01-20       Impact factor: 5.948

7.  Cytotoxic T lymphocyte and natural killer cell responses to non-typeable Haemophilus influenzae.

Authors:  P T King; J Ngui; M W Farmer; P Hutchinson; P W Holmes; S R Holdsworth
Journal:  Clin Exp Immunol       Date:  2008-06       Impact factor: 4.330

8.  Predicting Healthcare Utilization by Patients Admitted for COPD Exacerbation.

Authors:  Karthikeyan Ramaraju; Anupama Murthy Kaza; Nithilavalli Balasubramanian; Siddhuraj Chandrasekaran
Journal:  J Clin Diagn Res       Date:  2016-02-01

9.  The role of toll-like receptors in acute and chronic lung inflammation.

Authors:  Erin I Lafferty; Salman T Qureshi; Markus Schnare
Journal:  J Inflamm (Lond)       Date:  2010-11-25       Impact factor: 4.981

10.  Haemophilus influenzae and the lung (Haemophilus and the lung).

Authors:  Paul King
Journal:  Clin Transl Med       Date:  2012-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.